European Companies Search Engine
EU funding (€3,929,699): Innovation in modelling Placenta for Maternal and Fetal Health Hor 28 Aug 2017 EU Research and Innovation programme "Horizon"
Text
Innovation in modelling Placenta for Maternal and Fetal Health
“The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . Innovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a European Training Network (ETN), and will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal Health. iPLACENTA will improve our ability to study, model and visualise the placenta. iPLACENTA focuses on doctoral-level training and will be delivered by eleven participating universities located in ten different European countries. It coordinates research and training collaboration among world-leading academic institutions in Europe, providing a new combination of in-depth international expertise. iPLACENTA’s unique network aims are to improve our ability to study the placenta through in vitro and mathematical modelling (WP1&2). Whilst enhancing visualisation and assessment of the placenta in animal models and the clinic, thus enhancing investigation and prognosis of complicated pregnancies. To link the research to industrial exploitation, the network brings together three different businesses; Mimetas (MIM) (organ-on-a-chip developer) as a beneficiary, and Moor, a clinical-technology specialist, and industrial global brand FujifFilm VisualSonics (FUJ) as partners. Together they will work with academics and clinicians to develop new placenta-on-a-chip technology (WP1), in silico placenta modelling (WP2), new modalities of laser technology to visualise the placenta in vivo (WP3), improve maternal-cardiovascular assessment and validate novel ultrasound tools for diagnosis of complicated pregnancies (WP3). Cross-sectorial training delivered by Business and Law Schools, Industry, Clinical specialist and European leaders in OpenScience-OpenInnovation.
Funded Companies:
| Company name | Funding amount |
| Action on Pre-Eclampsia | ? |
| Aston University | €273,288 |
| Fundacion para La Investigacion del Hospital Universitario La Fe de La Comunidad Valenciana | €247,873 |
| Institut National de la Sante et de la Recherche Medicale | €525,751 |
| Katholieke Universiteit Leuven | €250,560 |
| Mimetas B.V. | €510,749 |
| St George's Hospital Medical School | €546,576 |
| Universita Degli Studi Di Torino | €258,061 |
| Universitaet Rostock | €249,216 |
| Universiteit Maastricht | €255,374 |
| University College Cork - National University of Ireland, Cork | €265,675 |
| University of Dundee | €546,576 |
Source: https://cordis.europa.eu/project/id/765274
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Action on Pre-Eclampsia, Evesham.
